A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce

Get the lowdown on high finance each week with Barron’s columnist Jack Hough. Business leaders and trendspotters, insights and absurdities—this is Wall Street like you've never heard before.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Big Data will strain the electricity grid, says BofA. And Jack talks with a top energy analyst.

Learn more about your ad choices. Visit megaphone.fm/adchoices

A.I. Power Shortage. Plus, Oil & Gas Stock Picks

William Blair Analyst Sharon Zackfia talks restaurants including Chipotle, Sweetgreen and CAVA. Jack assesses his relationship with Siri.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Why Starbucks Went Cold. Plus, Apple’s A.I. Opportunity.

Sands Capital semiconductor analyst Daniel Pilling shares insights. Plus, more drama at Paramount.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Chip Stocks and the A.I. Explosion

Plus, the charms of CLOs. BofA’s Jared Woodard sizes up income strategies.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Problem With Covered Call Writing

Plus, Tesla earnings, European stock picks, and jellied eels.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce

Download our free app to listen on your phone